Schizophrenia Clinical Trials in Hartford, Connecticut

4 studies are recruiting for schizophrenia in Hartford, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of Brenipatide in Adult Participants With Schizophrenia

    The purpose of this study is to assess the efficacy and safety of brenipatide when administered with standard of care (SoC) compared to placebo plus SoC for treatment of schizophrenia. The trial is divided into three periods as follows: Screening period will last approximately 1 month, treatment pe…

    Stage
    Phase 2
    Ages
    18 to 55
    Site
    Institute of Living, Hartford, Connecticut
    Locations
    103 in total
    Run by
    Eli Lilly and Company

    See if you can join NCT07410507 on ClinicalTrials.gov

  2. Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

    To compare changes in body mass index (BMI) Z-score following treatment with OLZ/SAM vs olanzapine

    Stage
    Phase 3
    Ages
    10 to 17
    Site
    Alkermes Investigator Site, Hartford, Connecticut
    Locations
    47 in total
    Run by
    Alkermes, Inc.

    See if you can join NCT05303064 on ClinicalTrials.gov

  3. CLOZAPINE Response in Biotype-1

    The CLOZAPINE study is designed as a multisite study across 5 sites and is a clinical trial, involving human participants who are prospectively assigned to an intervention. The study will utilize a stringent randomized, double-blinded, parallel group clinical trial design. B2 group will serve as ps…

    Stage
    Phase 4
    Ages
    18 to 60
    Site
    Hartford Healthcare, Hartford, Connecticut
    Locations
    5 in total
    Run by
    University of Texas Southwestern Medical Center

    See if you can join NCT04580134 on ClinicalTrials.gov

  4. Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

    The Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services (BICEPS) study aims to understand the early stages of psychotic disorders like Schizophrenia, Schizoaffective Disorder, and Bipolar I Disorder. It involves gathering mental health information, brain scans (MRI), eye movement …

    Stage
    Not phased
    Ages
    18 to 40
    Site
    Hartford Hospital, Hartford, Connecticut
    Locations
    6 in total
    Run by
    Beth Israel Deaconess Medical Center

    See if you can join NCT06740383 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.